1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Viscosupplementation - Pipeline Review, 2015

Viscosupplementation - Pipeline Review, 2015

  • June 2015
  • -
  • Global Data
  • -
  • 37 pages

Viscosupplementation - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Viscosupplementation - Pipeline Review, 2015" provides an overview of Viscosupplementation currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Viscosupplementation pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type

Scope

- Extensive coverage of the Viscosupplementation under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Viscosupplementation and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Viscosupplementation under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Viscosupplementation - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Viscosupplementation Overview 5
3 Products under Development 6
3.1 Viscosupplementation - Pipeline Products by Stage of Development 6
3.2 Viscosupplementation - Pipeline Products by Territory 7
3.3 Viscosupplementation - Pipeline Products by Regulatory Path 8
3.4 Viscosupplementation - Pipeline Products by Estimated Approval Date 9
3.5 Viscosupplementation - Ongoing Clinical Trials 10
4 Viscosupplementation - Pipeline Products under Development by Companies 11
4.1 Viscosupplementation Companies - Pipeline Products by Stage of Development 11
4.2 Viscosupplementation - Pipeline Products by Stage of Development 12
5 Viscosupplementation Companies and Product Overview 13
5.1 Anika Therapeutics, Inc. Company Overview 13
5.1.1 Anika Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 13
5.2 BioPolymer GmbH and Co. KG Company Overview 17
5.2.1 BioPolymer GmbH and Co. KG Pipeline Products and Ongoing Clinical Trials Overview 17
5.3 Carbylan Therapeutics, Inc. Company Overview 19
5.3.1 Carbylan Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 19
5.4 Chi2Gel Ltd. Company Overview 25
5.4.1 Chi2Gel Ltd. Pipeline Products and Ongoing Clinical Trials Overview 25
5.5 Cocoon Biotech, Inc. Company Overview 26
5.5.1 Cocoon Biotech, Inc. Pipeline Products and Ongoing Clinical Trials Overview 26
5.6 Flex Biomedical, Inc. Company Overview 27
5.6.1 Flex Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
5.7 Moebius Medical Ltd. Company Overview 28
5.7.1 Moebius Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 28
5.8 OrthogenRx Inc. Company Overview 29
5.8.1 OrthogenRx Inc. Pipeline Products and Ongoing Clinical Trials Overview 29
5.9 Synolyne Pharma Company Overview 30
5.9.1 Synolyne Pharma Pipeline Products and Ongoing Clinical Trials Overview 30
5.10 University of Kansas Company Overview 31
5.10.1 University of Kansas Pipeline Products and Ongoing Clinical Trials Overview 31
6 Viscosupplementation- Recent Developments 32
7 Appendix 35
7.1 Methodology 35
7.2 About GlobalData 37
7.3 Contact Us 37
7.4 Disclaimer 37

1.1 List of Tables
Table 1: Viscosupplementation - Pipeline Products by Stage of Development 6
Table 2: Viscosupplementation - Pipeline Products by Territory 7
Table 3: Viscosupplementation - Pipeline Products by Regulatory Path 8
Table 4: Viscosupplementation - Pipeline Products by Estimated Approval Date 9
Table 5: Viscosupplementation - Ongoing Clinical Trials 10
Table 6: Viscosupplementation Companies - Pipeline Products by Stage of Development 11
Table 7: Viscosupplementation - Pipeline Products by Stage of Development 12
Table 8: Anika Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 13
Table 9: Cingal - Product Status 13
Table 10: Cingal - Product Description 14
Table 11: Anika Therapeutics, Inc. - Ongoing Clinical Trials Overview 15
Table 12: Cingal - To Evaluate the Safety of a Repeat Injection of Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee (Cingal 13-02: An Open-label, Follow-on Study to Cingal 13-01) 16
Table 13: BioPolymer GmbH and Co. KG Pipeline Products and Ongoing Clinical Trials Overview 17
Table 14: Crespine Gel - Product Status 17
Table 15: Crespine Gel - Product Description 17
Table 16: Crespine Gel Plus - Product Status 18
Table 17: Crespine Gel Plus - Product Description 18
Table 18: Carbylan Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 19
Table 19: Hydros - Product Status 19
Table 20: Hydros - Product Description 19
Table 21: Hydros TA - Product Status 20
Table 22: Hydros TA - Product Description 20
Table 23: Hydros TA - Hip - Product Status 21
Table 24: Hydros TA - Hip - Product Description 21
Table 25: Carbylan Therapeutics, Inc. - Ongoing Clinical Trials Overview 22
Table 26: Hydros - A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated wWith Osteoarthritis in the Knee 23
Table 27: Hydros TA - A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated wWith Osteoarthritis in the Knee 24
Table 28: Chi2Gel Ltd. Pipeline Products and Ongoing Clinical Trials Overview 25
Table 29: Chi2Knee - Product Status 25
Table 30: Chi2Knee - Product Description 25
Table 31: Cocoon Biotech, Inc. Pipeline Products and Ongoing Clinical Trials Overview 26
Table 32: Silk Hydrogel - Product Status 26
Table 33: Silk Hydrogel - Product Description 26
Table 34: Flex Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
Table 35: Flex Polymer - Product Status 27
Table 36: Flex Polymer - Product Description 27
Table 37: Moebius Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 28
Table 38: MM-II - Product Status 28
Table 39: MM-II - Product Description 28
Table 40: OrthogenRx Inc. Pipeline Products and Ongoing Clinical Trials Overview 29
Table 41: OrthogenRx Device - Product Status 29
Table 42: OrthogenRx Device - Product Description 29
Table 43: Synolyne Pharma Pipeline Products and Ongoing Clinical Trials Overview 30
Table 44: Arthrovisc - Product Status 30
Table 45: Arthrovisc - Product Description 30
Table 46: University of Kansas Pipeline Products and Ongoing Clinical Trials Overview 31
Table 47: 3-D Colloidal Gel - Product Status 31
Table 48: 3-D Colloidal Gel - Product Description 31
Table 49: Glossary 36

1.2 List of Figures
Figure 1: Viscosupplementation - Pipeline Products by Stage of Development 6
Figure 2: Viscosupplementation - Pipeline Products by Territory 7
Figure 3: Viscosupplementation - Pipeline Products by Regulatory Path 8
Figure 4: Viscosupplementation - Pipeline Products by Estimated Approval Date 9
Figure 5: Viscosupplementation - Ongoing Clinical Trials 10

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Therapy Market in Denmark - Forecast

  • December 2016
    12 pages
  • Therapy  

  • Denmark  

View report >

Related Market Segments :

Therapy

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.